Comparison of lenvatinib plus pembrolizumab versus firstline systemic chemotherapy for advanced intrahepatic cholangiocarcinoma: A real-world retrospective study

被引：0
|
作者：
Yang, Z. [1 ]
Hu, D. [1 ]
Chen, M. [1 ]
机构：
[1] Sun Yat Sen Univ, Dept Liver Surg, Canc Ctr, Guangzhou, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.05.449
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
306P
引用
收藏
页码：S129 / S129
页数：1
相关论文
共 50 条
  • [21] Hepatic arterial infusion chemotherapy plus regorafenib in advanced colorectal cancer: a real-world retrospective study
    Cao, Guang
    Wang, Xiaodong
    Chen, Hui
    Gao, Song
    Guo, Jianhai
    Liu, Peng
    Xu, Haifeng
    Xu, Liang
    Zhu, Xu
    Yang, Renjie
    BMC GASTROENTEROLOGY, 2022, 22 (01)
  • [22] Hepatic arterial infusion chemotherapy plus regorafenib in advanced colorectal cancer: a real-world retrospective study
    Guang Cao
    Xiaodong Wang
    Hui Chen
    Song Gao
    Jianhai Guo
    Peng Liu
    Haifeng Xu
    Liang Xu
    Xu Zhu
    Renjie Yang
    BMC Gastroenterology, 22
  • [23] Systemic chemotherapy plus transarterial chemoembolization versus systemic chemotherapy alone for unresectable intrahepatic cholangiocarcinoma: a multicenter retrospective cohort study (vol 129, pg 631, 2024)
    Jiang, Nan
    Zhang, Ze
    Yin, Xiaoxv
    Qiu, Huaiming
    Yan, Weipeng
    Hao, Yonghong
    Yang, Wenhua
    Li, Hualing
    Xu, Anhui
    Mu, Ketao
    RADIOLOGIA MEDICA, 2024, 129 (06): : 955 - 955
  • [24] Real-world experience of pembrolizumab in patients with advanced melanoma: A large retrospective observational study
    Liu, F. X.
    Ou, W.
    Diede, S. J.
    Whitman, E. D.
    ANNALS OF ONCOLOGY, 2018, 29
  • [25] Real-world experience with pembrolizumab in patients with advanced melanoma A large retrospective observational study
    Liu, Frank Xiaoqing
    Ou, Wanmei
    Diede, Scott J.
    Whitman, Eric D.
    MEDICINE, 2019, 98 (30) : e16542
  • [26] Real-world comparison of pembrolizumab and nivolumab in advanced hepatocellular carcinoma
    Yen-Hao Chen
    Ching-Hua Tsai
    Yen-Yang Chen
    Chih-Chi Wang
    Jing-Houng Wang
    Chao-Hung Hung
    Yuan-Hung Kuo
    BMC Cancer, 23
  • [27] Real-world comparison of pembrolizumab and nivolumab in advanced hepatocellular carcinoma
    Chen, Yen-Hao
    Tsai, Ching-Hua
    Chen, Yen-Yang
    Wang, Chih-Chi
    Wang, Jing-Houng
    Hung, Chao-Hung
    Kuo, Yuan-Hung
    BMC CANCER, 2023, 23 (01)
  • [28] Efficacy, safety, and prognostic factors of PD-1 inhibitors combined with lenvatinib and Gemox chemotherapy as first-line treatment in advanced intrahepatic cholangiocarcinoma: a multicenter real-world study
    Zhu, Chengpei
    Li, Hu
    Yang, Xiaobo
    Wang, Shanshan
    Wang, Yunchao
    Zhang, Nan
    Wang, Yanyu
    Xue, Jingnan
    Zhang, Longhao
    Ning, Cong
    Yang, Xu
    Xun, Ziyu
    Chao, Jiashuo
    Long, Junyu
    Sang, Xinting
    Zhu, Zhenyu
    Zhao, Haitao
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (09) : 2949 - 2960
  • [29] Efficacy, safety, and prognostic factors of PD-1 inhibitors combined with lenvatinib and Gemox chemotherapy as first-line treatment in advanced intrahepatic cholangiocarcinoma: a multicenter real-world study
    Chengpei Zhu
    Hu Li
    Xiaobo Yang
    Shanshan Wang
    Yunchao Wang
    Nan Zhang
    Yanyu Wang
    Jingnan Xue
    Longhao Zhang
    Cong Ning
    Xu Yang
    Ziyu Xun
    Jiashuo Chao
    Junyu Long
    Xinting Sang
    Zhenyu Zhu
    Haitao Zhao
    Cancer Immunology, Immunotherapy, 2023, 72 : 2949 - 2960
  • [30] The efficacy and safety of lenvatinib for advanced hepatocellular carcinoma in China: A retrospective, real-world study.
    Yang, Xin-Rong
    Guo, De-Zhen
    Chen, Fei-Yu
    Fan, Jia
    Jian, Zhou
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345